載入...
Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report
BACKGROUND: Collecting duct carcinoma (CDC) of the kidney is a rare and highly aggressive malignant tumor with the worst prognosis among all renal cancers. Nevertheless, the first-line treatments, including chemotherapy and target therapy, usually show poor response to CDC. Recent studies have sugge...
Na minha lista:
| 發表在: | J Immunother Cancer |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BMJ Publishing Group
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7247377/ https://ncbi.nlm.nih.gov/pubmed/32439798 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000217 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|